Skip to main content

Aro Biotherapeutics identifies a lead target for its centyrins technology

"Our hope is we can provide a new approach to treating this truly devastating disease."
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.